MEREO BIOPHARMA GROUP PLC (MREO) Shareholders’ equity 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) shareholders’ equity at each fiscal year-end, per SEC filings.
$40.9MFY2025 · since FY2022: $51.4M → $40.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $40.9M | -32.9% |
| FY2024 | $61.0M | +20.6% |
| FY2023 | $50.5M | -1.7% |
| FY2022 | $51.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice